Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Nephrologists' management of patient medications in kidney transplantation: results of an online survey

Crawford K, Low JK, Manias E, Walker R, Toussaint N, Mulley W, Dooley MJ, Ierino F, Hughes P, Goodman D, Williams A

(2015), J Eval Clin Pract, 21(5), 879-85

Postoperative bleeding after administration of a single dose of rivaroxaban to a patient receiving antiretroviral therapy

Corallo CE, Grannell L, Tran H

(2015), Drug Safety Case Rep, 2, 11

A case of ST elevation myocardial infarction precipitated by methylphenidate for gait freeze

Connell CE, Gellatly R, Dooley MJ, Shaw J

(2015), J Pharm Pract Res, 45(2), 174-7

Management of acute agitation in Hong Kong and comparisons with Australasia

Chan EW, Tang C, Lao KS, Ling Pong L, Tsui MS, Ho HF, Wong GC, Kong DC, McD Taylor D, Knott JC, Wong IC

(2015), Emerg Med Australas, 27, 542-8

Scottish antimicrobial stewardship preceptorship

Cairns K

(2015), J Pharm Pract Res, 45(2), 245-7

Antimicrobial stewardship in Australian hospitals and other settings

Cairns KA, Roberts JA, Cotta MO, Cheng AC

(2015), Infect Dis Ther, 4(Suppl 1), 27-38

Modifying chemotherapeutic management of a patient with Burkitt’s lymphoma and pre-existing motor neurone disease

Bortz H, Coutsouvelis J, Corallo CE, Spencer A, Patil S

(2015), J Clin Pharm Ther, 40(4), 483-5

Safe disposal of prescribed medicines

Bergen PJ, Hussainy SY, George J, Kong DC, Kirkpatrick CM

(2015), Aust Prescr, 38(3), 90-2

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB

(2015), Haematologica, 100(7), 914-26

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange V, Maertens J, Derigs HG, Heuser M, Damon L, Powell BL, Gaidano G, Carella AM, Wei A, Hogge D, Craig AR, Fox JA, Ward R, Smith JA, Acton G, Mehta C, Stuart RK, Kantarjian HM

(2015), Lancet Oncol, 16(9), 1025-36

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling VY, Lee D, McQuilten Z, Avery S, Low M, Cody SH, Nguyen T, McLean C, Gorniak M, Wei A, Ting SB

(2015), Am J Hematol, 90(12), E219-20

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM

(2015), Clin Toxicol, 53(3), 156-63

Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants

Cohen A, Jeyaindran S, Kim JY, Park K, Sompradeekul S, Tambunan KL, Tran H, Tsai IC, Ward C, Wong R

(2015), Thromb Res, 136(2), 196-207

Heparin induced thrombocytopenia in critically ill: diagnostic dilemmas and management conundrums

Gupta S, Tiruvoipati R, Green C, Botha J, Tran H

(2015), World J Crit Care Med, 4(3), 202-12

Isolated iliac vein thrombosis in pregnancy

Keragala CB, Cummins KD, Goergen SK, Shipp D, Chunilal S

(2015), Intern Med J, 45(4), 460-1

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A

(2015), Br J Haematol, 169(2), 199-210

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Pham T, Patil S, Fleming S, Avery S, Walker P, Wei A, Curtis D, Stuart G, Klarica D, O'Brien M, Morris K, Das T, Bollard G, Muirhead J, Coutsouvelis J, Spencer A

(2015), Transfusion, 55(11), 2709-13

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia

Kalff A, Khong T, Wall M, Gorniak M, Mithraprabhu S, Campbell LJ, Spencer A

(2015), Haematologica, 100(2), e60-2

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Mithraprabhu S, Kalff A, Chow A, Khong T, Spencer A

(2015), Epigenetics, 9(11), 1511-20

The role of multiparametric flow cytometry in the detection of minimal residual disease in acute leukaemia

Lee D, Grigoriadis G, Westerman D

(2015), Pathology, 47(7), 609-21

332 333 334 335 336